C. Gary Marshall

2.7k citations

28 papers · 1.5k indexed · h-index 17

Impact in

Pharmacology top 1%
- Microbial Natural Products and Biosynthesis
Molecular Medicine top 5%
- Antibiotic Resistance in Bacteria

Papers in

Pharmacology 10
- Microbial Natural Products and Biosynthesis 10
Endocrinology 3

Co-authors: Christopher T. Walsh Thomas A. Keating Gerard D. Wright Brian K. Hubbard Amy E. Keating Ivan A.D. Lessard Deborah A. Miller Lusong Luo
Journals: Biochemistry (6 papers)Bioorganic & Medicinal Chemistry Letters (4 papers)Molecular Cancer Therapeutics (3 papers)ChemBioChem (2 papers)Proceedings of the National Academy of Sciences (2 papers)
Partner nations: United States Canada

In The Last Decade

C. Gary Marshall

28 papers receiving 1.5k citations

Peers

Countries citing papers authored by C. Gary Marshall

Since Specialization

Citations

This map shows the geographic impact of C. Gary Marshall's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by C. Gary Marshall with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites C. Gary Marshall more than expected).

Fields of papers citing papers by C. Gary Marshall

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by C. Gary Marshall. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by C. Gary Marshall. The network helps show where C. Gary Marshall may publish in the future.

Co-authors

The 25 scholars most cited alongside C. Gary Marshall, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with C. Gary Marshall Line = papers co-authored together C. Gary Marshall links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Abstract B057: Preclinical development of PKMYT1 and ATR inhibitor combinations Molecular Cancer Therapeutics ·David A. Gallo, Marc L. Hyer, Giovanni Martino, Lígia Melo Vidal, Elia Aguado-Fraile, P. Mohanty, Melody Carter, Rino Stocco, Stephen Morris, C. Gary Marshall, Anne Roulston, Michael Zinda, Michal Zimmermann	2023	1
2	Abstract C163: KRAS alterations combined with TP53 mutations as novel synthetic lethal genomic lesions for PKMYT1 inhibition Molecular Cancer Therapeutics ·Marc L. Hyer, Melody Carter, David A. Gallo, Vivek Bhaskaran, Rino Stocco, P. Mohanty, Anton Kolesnikov, Helen E. Burston, Katja Sorta, Stephen Morris, Anne Roulston, Jordan T.F. Young, Michal Zimmermann, C. Gary Marshall, Artur Veloso, Elia Aguado-Fraile	2023	2
3	Abstract 5650: RP-6306, a novel PKMYT1 inhibitor, demonstrates synthetic lethality as monotherapy and in combination with gemcitabine in CCNE1 amplified cancer cells Cancer Research ·Melody Carter, Alvina Ghina Riyanita, Rino Stocco, Kawthar Ali, Nicole M. Duffy, David A. Gallo, Ethan Anderson, Jingjing Li, Li Li, Xuanguang Hu, Iva Strnadov, Anne Roulston, Yaël Mamane, Stephen Morris, Janek Szychowski, Mitsuhiro Toma, YU Shou-hong, C. Gary Marshall	2022	1
4	Discovery of novel N-hydroxy-2-arylisoindoline-4-carboxamides as potent and selective inhibitors of HDAC11 Bioorganic & Medicinal Chemistry Letters ·Matthew W. Martin, Jennifer Y. Lee, David R. Lancia, Pui Yee Ng, Bingsong Han, Jennifer R. Thomason, Maureen S. Lynes, C. Gary Marshall, Chiara Conti, Alan Collis, 冨田浩史, Magdalena Campion, André Akoun, Lili Yao, Xiaozhang Zheng	2018	41
5	Thiophene carboxamide inhibitors of JAK2 as potential treatments for myleoproliferative neoplasms Bioorganic & Medicinal Chemistry Letters ·Andrew M. Haidle, M I Yu, L Fleury, Craig Rosenstein, Indah Dwi Astutik, Michael D. Altman, Grace Chan, Lin Xu, Eric Bachman, Jan-Rung Mo, P.P. Silva, Thomas S. Rush, Paul Tempest, C. Gary Marshall, Jonathan R. Young	2014	9
6	The discovery of reverse tricyclic pyridone JAK2 inhibitors. Part 2: Lead optimization Bioorganic & Medicinal Chemistry Letters ·Tony Siu, Jonathan Schnelzer, Michael D. Altman, Matthew H. Katcher, Alan B. Northrup, Catherine A. White, Craig Rosenstein, Indah Dwi Astutik, Lin Xu, Grace Chan, Eric Bachman, P.P. Silva, Christopher J. Dinsmore, C. Gary Marshall, Jonathan R. Young	2014	6
7	The discovery of tricyclic pyridone JAK2 inhibitors. Part 1: Hit to lead Bioorganic & Medicinal Chemistry Letters ·Tony Siu, DG Fry, Joon Jung, Craig Rosenstein, Indah Dwi Astutik, Michael D. Altman, Grace Chan, Lin Xu, Eric Bachman, Jan-Rung Mo, P.P. Silva, Thomas S. Rush, Christopher J. Dinsmore, C. Gary Marshall, Jonathan R. Young	2010	22
8	Real-time bioluminescence imaging of polycythemia vera development in mice Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease ·Yanhong Ma, Shuxia Zhao, Joe Jiang Zhu, M. A. Jamadar Dr. M. A. Jamadar, Xianlu Qu, C. Gary Marshall, Jonathan R. Young, Nancy E. Kohl, Martin Scott, Weisheng Zhang, Yuxun Wang	2009	2
9	Characterization of inhibitor binding to human kinesin spindle protein by site-directed mutagenesis Archives of Biochemistry and Biophysics ·C. Gary Marshall, Maricel Torrent, Olusegun Williams, Kelly Hamilton, Carolyn A. Buser	2009	12
10	Abstract C204: Inhibition of c-Met signaling in combination with cisplatin and 5-fluorouracil significantly enhances antitumor effects in gastric cancer models Molecular Cancer Therapeutics ·Clay L. Efferson, Linda Lee, Jennifer Tammam, Chris Ware, Sujal V. Deshmukh, Elizabeth A. Harrington, Bo‐Sheng Pan, John F. Reilly, Pradip K. Majumder, C. Gary Marshall	2009	1
11	The glycopeptide antibiotic producer Streptomyces toyocaensis NRRL 15009 has both d-alanyl-d-alanine and d-alanyl-d-lactate ligases FEMS Microbiology Letters ·C. Gary Marshall, Gerard D. Wright	2006	11
12	RNA Interference-Mediated Silencing of Mitotic Kinesin KIF14 Disrupts Cell Cycle Progression and Induces Cytokinesis Failure Molecular and Cellular Biology ·Michael Carleton, Mao Mao, Matthew C. Biery, Paul Warrener, Мирослав Стойка, Carolyn A. Buser, C. Gary Marshall, Christine Fernandes, James Annis, Peter S. Linsley	2006	100
13	The structure of VibH represents nonribosomal peptide synthetase condensation, cyclization and epimerization domains Nature Structural Biology ·Thomas A. Keating, C. Gary Marshall, Christopher T. Walsh, Amy E. Keating	2002	189
14	Carrier Protein Recognition in Siderophore-Producing Nonribosomal Peptide Synthetases Biochemistry ·C. Gary Marshall, Michael D. Burkart, Sergio Miguel García, Christopher T. Walsh	2002	22
15	Chain Termination Steps in Nonribosomal Peptide Synthetase Assembly Lines: Directed Acyl-S-Enzyme Breakdown in Antibiotic and Siderophore Biosynthesis ChemBioChem ·Thomas A. Keating, David E. Ehmann, Rahul M. Kohli, C. Gary Marshall, John W. Trauger, Christopher T. Walsh	2001	62
16	Tailoring enzymes that modify nonribosomal peptides during and after chain elongation on NRPS assembly lines Current Opinion in Chemical Biology ·Christopher T. Walsh, Huawei Chen, Thomas A. Keating, Brian K. Hubbard, Heather C. Losey, Lusong Luo, C. Gary Marshall, Deborah A. Miller, Hiten M. Patel	2001	230
17	Catalytic Mapping of the Vibriobactin Biosynthetic Enzyme VibF Biochemistry ·C. Gary Marshall, Nathan J. Hillson, Christopher T. Walsh	2001	76
18	Chain Termination Steps in Nonribosomal Peptide Synthetase Assembly Lines: Directed Acyl-S-Enzyme Breakdown in Antibiotic and Siderophore Biosynthesis ChemBioChem ·Thomas A. Keating, David E. Ehmann, Rahul M. Kohli, C. Gary Marshall, John W. Trauger, Christopher T. Walsh	2001	3
19	Molecular Mechanism of VanHst, an α-Ketoacid Dehydrogenase Required for Glycopeptide Antibiotic Resistance from a Glycopeptide Producing Organism Biochemistry ·C. Gary Marshall, Ren Malabiau, Gerard D. Wright	1999	13
20	DdlN from Vancomycin-Producing Amycolatopsis orientalis C329.2 Is a VanA Homologue with d -Alanyl- d -Lactate Ligase Activity Journal of Bacteriology ·C. Gary Marshall, Gerard D. Wright	1998	19

About C. Gary Marshall

C. Gary Marshall is a scholar working on Pharmacology, Endocrinology, Genetics, Oncology and Hematology, having authored 28 papers that have together received 1.5k indexed citations. Recurring topics across this work include Microbial Natural Products and Biosynthesis (10 papers), Biochemical and Structural Characterization (6 papers), Cytokine Signaling Pathways and Interactions (5 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (5 papers), Bacterial Genetics and Biotechnology (5 papers), Chemical Synthesis and Analysis (4 papers), Microtubule and mitosis dynamics (4 papers) and Genomics and Phylogenetic Studies (4 papers). The work is most often cited by research in Pharmacology (799 citations), Molecular Medicine (135 citations), Biotechnology (170 citations), Molecular Biology (1.0k citations) and Microbiology (85 citations). C. Gary Marshall has collaborated with scholars based in United States and Canada. Frequent co-authors include Christopher T. Walsh, Thomas A. Keating, Gerard D. Wright, Brian K. Hubbard, Amy E. Keating, Ivan A.D. Lessard, Deborah A. Miller, Lusong Luo, Hiten M. Patel and Huawei Chen. Their work appears in journals such as Biochemistry, Bioorganic & Medicinal Chemistry Letters, Molecular Cancer Therapeutics, ChemBioChem and Proceedings of the National Academy of Sciences.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact